Evidence map›Paper›PMID 26919990›Full record

ReviewCurrent genetics2016

The repeatability of genome-wide mutation rate and spectrum estimates.

Megan G Behringer, David W Hall

Abstract readReview
In one paragraph

Review in Current genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Investigating Fission Yeast Mutagenesis Using Canavanine Sensitivity Assays.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  3. Article
  4. Recent insights into the evolution of mutation rates in yeast.Current opinion in genetics & development · 2022
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Megan G BehringerDepartment of Biology, Indiana University, 1001 East Third Street, Bloomington, 47405, IN, USA. megbehri@indiana.edu.
David W HallDepartment of Genetics, University of Georgia, Athens, 3060, Georgia.

Funding

T32 Predoctoral training grant in geneticsT32GM007103 · NIGMS · UNIVERSITY OF GEORGIA (UGA) · PI DYER, KELLY A · 1985 to 2021
$5.9M
Sequencing yeast lines to measure rates of neutral and deleterious mutationsR01GM097415 · NIGMS · NEW YORK UNIVERSITY · PI PETROV, DMITRI, SIEGAL, MARK L · 2011 to 2014
$2.3M
NIGMS NIH HHS R01 GM097415NIGMS NIH HHS T32 GM007103
6 · The paper itself

Abstract

Over the last decade, mutation studies have grown in popularity due to the affordability and accessibility of whole genome sequencing. As the number of species in which spontaneous mutation has been directly estimated approaches 20 across two domains of life, questions arise over the repeatability of results in such experiments. Five species were identified in which duplicate mutation studies have been performed. Across these studies the difference in estimated spontaneous mutation rate is at most, weakly significant (p < 0.01). However, a highly significant (p < 10(-5)), threefold difference in the rate of insertions/deletions (indels) exists between two recent studies in Schizosaccharomyces pombe. Upon investigation of the ancestral genome sequence for both studies, a possible anti-mutator allele was identified. The observed variation in indel rate may imply that the use of indel markers, such as microsatellites, for the investigation of genetic diversity within and among populations may be inappropriate because of the assumption of uniform mutation rate within a species.

Indexed as

Genome, FungalGenomicsMutationMutation RateEvolution, MolecularINDEL MutationMicrosatellite RepeatsPolymorphism, Single NucleotideReproducibility of ResultsYeastsDNA repairEvolutionindelMicrosatelliteMutation accumulationSchizosaccharomyces pombeYeast

Identifiers

PMID26919990
PMCPMC4930417

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.